House Committee Will Cause Controversy by Bundling Oral Kidney Meds in Medicare Bill

Amgen and Genzyme are expected to fight language in the House draft bill for health care reform that would bundle oral kidney meds into payments for dialysis treatments, Bernstein analyst predicts.